About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Blogs

BIS Publishes New Guidance on CDE Governance

Subscribe to our newsletter

The Bank of International Settlements (BIS), parent of the Basel Committee, has published new guidance on global governance arrangements to harmonise the usage and reporting of critical OTC derivatives data elements (CDE).

The new guidelines follow the decision taken by the G20 back in 2009 requiring all OTC derivatives transactions to be reported to trade repositories (TRs) in order to improve transparency, mitigate systemic risk and prevent market abuse. However, in order to aggregate that data to give regulators a comprehensive overview of the trading landscape, the disparate data elements must be standardised and harmonised.

In October 2019 the Committee on Payments and Market infrastructures (CPMI) and the International Organization of Securities Commissions (IOSCO), under the BIS banner, published a new report identifying key criteria, functions and bodies for the governance arrangements for CDE, excluding the Unique Transaction Identifier (UTI) and the Unique Product Identifier (UPI).

The new governance covers three broad areas: maintenance, oversight, and implementation.

In coordination with the Financial Stability Board (FSB), in its capacity as the international body in charge of defining governance arrangements for the UTI and UPI,  the report concludes that the Legal Entity Identifier Regulatory Oversight Committee is best positioned to take on the role of the international governance body for critical data elements by mid-2020, subject to some necessary adjustments to its own governance. In the interim, the FSB will perform this role.

CPMI and IOSCO also recommend that jurisdictions take steps to implement the governance arrangements across jurisdictions within three years from the publication of the report.

In 2014 the FSB conducted a Feasibility Study on approaches to aggregate OTC derivatives data, and asked global guidance based on the results. This report is the final part of CPMI and IOSCO’s response to that mandate, and complements the previously published Technical guidance on harmonisation of the UTI, the Technical guidance on harmonisation of the UPI and the Technical guidance on harmonisation of critical OTC derivatives data elements (other than UTI and UPI).

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: The challenges and potential of data marketplaces

Data is the lifeblood of capital markets. It is also a valuable commodity providing financial institutions with additional insight when gathered in an internal data marketplace, or packaged and sold externally to other institutions. While the theory is sound, the practice of setting up a data marketplace can be challenging. Internally, vast amounts of data...

BLOG

WCM Investment Management Cuts Reconciliation Time with Gresham Managed Services

WCM Investment Management has cut reconciliation time by two-thirds after tripling assets under management (AUM) over the past three years by using Gresham Technologies cloud-based managed services to aggregate data from more than 55 custodians and reconcile positions, transactions, cash and foreign currencies across 1,500 accounts and 2,500 cash buckets. WCM, an independent fund and...

EVENT

RegTech Summit London

Now in its 6th year, the RegTech Summit in London will bring together the RegTech ecosystem to explore how the European capital markets financial industry can leverage technology to drive innovation, cut costs and support regulatory change.

GUIDE

Regulatory Data Handbook 2022/2023 – Tenth Edition

Welcome to the tenth edition of A-Team Group’s Regulatory Data Handbook, a publication that has tracked new regulations, amendments, implementation and data management requirements as regulatory change has impacted global capital markets participants over the past 10 years. This edition of the handbook includes new regulations and highlights some of the major regulatory interventions challenging...